Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2022   24,850,261      
Beginning balance at Dec. 31, 2022 $ 18,987,750 $ 24,850 $ 57,351,008 $ (38,281,548) $ (106,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 77,348   77,348    
Net income (18,060)     1,490,029  
Net income (loss) (1,471,969)       18,060
Ending balance (shares) at Mar. 31, 2023   24,850,261      
Ending balance at Mar. 31, 2023 17,593,129 $ 24,850 57,428,356 (39,771,577) (88,500)
Beginning balance (shares) at Dec. 31, 2023   24,850,261      
Beginning balance at Dec. 31, 2023 14,652,295 $ 24,850 57,601,402 (42,879,656) (94,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 44,535   44,535    
Net income (17,351)     1,104,967  
Net income (loss) (1,087,616)       17,351
Ending balance (shares) at Mar. 31, 2024   24,850,261      
Ending balance at Mar. 31, 2024 $ 13,609,214 $ 24,850 $ 57,645,937 $ (43,984,623) $ (76,950)